Cedar Brook Financial Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cedar Brook Financial Partners's AMGN Position: Q2 2024 in Review
Cedar Brook Financial Partners sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,285 shares — an estimated $365K sold.
Cedar Brook Financial Partners first reported a position in AMGN in Q1 2019 and held it in 20 quarters. The position peaked at $365K in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Cedar Brook Financial Partners reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
- Cedar Brook Financial Partners sold 1,285 Amgen shares in Q2 2024, an estimated $365K.
- Cedar Brook Financial Partners first reported a position in Amgen in Q1 2019 and held it in 20 quarters.
- Cedar Brook Financial Partners's Amgen position peaked at $365K in Q1 2024.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.